PUBLISHER: KBV Research | PRODUCT CODE: 1093597
PUBLISHER: KBV Research | PRODUCT CODE: 1093597
North America Wearable Injectors Market Size, Share & Industry Trends Analysis Report By Therapy (Diabetes, Cardiovascular disease, Immuno-oncology), By End User, By Type, By Technology, By Country and Growth Forecast, 2022 - 2028
The North America Wearable Injectors Market would witness market growth of 8.9% CAGR during the forecast period (2022-2028).
The device is intended to be prefilled with medicine and kept cold. The device container is approximately 76mm (3.0 inches) long in its current 3ml configuration. The needle enters the skin with the push of a button once the device is attached to the user's body. It should be spun 90 degrees anti-clockwise in the patient's hand. During the injection procedure, the device makes no noise. The needle retracts after completion, and the user can remove and dispose it. These devices significantly streamline the injection process, due to which, the demand for them is rapidly increasing among consumers.
Beyond the device's simplicity, wearable injectable devices provide a slew of advantages to users and medication companies. The device's capabilities enable it to give bigger dosages along with higher viscosities, and in some circumstances both. This is done while minimizing the patient's discomfort from higher doses and, in many situations, reducing the total number of injections required. These items can enable medication delivery in the patient's home rather than a clinical setting in cases where pharmaceuticals are supplied intravenously over extended periods of time, such as in the diagnosis of cancer or auto-immune illnesses. Keeping unnecessary time in the hospital or clinical setting to a minimum lowers the risk of hospital-acquired infections (HAIs).
Chronic diseases are long-term illnesses that develop gradually over time, typically worsening in severity, and can be regulated but not cured. Cardiovascular disorders (stroke and heart disease), cancer, arthritis, diabetes, back pain, asthma, and persistent depression are among them. Chronic diseases can drastically impair daily physical and mental processes, as well as limit one's capacity to undertake daily activities. Chronic diseases have surpassed infectious diseases as the primary cause of mortality and disability around the world. According to the Ministry of Health, noncommunicable illnesses currently account for 59% of the world's 57 million annual deaths and 46% of the global disease burden. The situation is very similar in Ontario. Heart disease was the biggest cause of death in the province in 2003, with myocardial infarction being the most common type of heart illness. Cancer, stroke, as well as a chronic obstructive pulmonary disease, were the next leading causes of death.
The US market dominated the North America Wearable Injectors Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,597.8 Million by 2028. The Canada market estimated to grow at a CAGR of 11.4% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 10.4% during (2022 - 2028).
Based on Therapy, the market is segmented into Diabetes, Cardiovascular disease, Immuno-oncology, and Others. Based on End User, the market is segmented into Hospitals & Clinics and Home healthcare setting. Based on Type, the market is segmented into On-body Injector and Off-body Injector. Based on Technology, the market is segmented into Spring Based, Motor Based, Rotary pump, Expanding battery, and others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Insulet Corporation, United Therapeutics Corporation, ATS Automation Tooling Systems, Inc., Ypsomed AG, Amgen, Inc., West Pharmaceutical Services, Inc., Zealand Pharma A/S (Valeritas, Inc.), Medtronic PLC, CeQur SA, and Subcuject ApS.
Scope of the Study
Market Segments covered in the Report:
By Therapy
- Diabetes
- Cardiovascular disease
- Immuno-oncology
- Others
By End User
- Hospitals & Clinics
- Home healthcare setting
By Type
- On-body Injector
- Off-body Injector
By Technology
- Spring Based
- Motor Based
- Rotary pump
- Expanding battery
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Insulet Corporation
- United Therapeutics Corporation
- ATS Automation Tooling Systems, Inc.
- Ypsomed AG
- Amgen, Inc.
- West Pharmaceutical Services, Inc.
- Zealand Pharma A/S (Valeritas, Inc.)
- Medtronic PLC
- CeQur SA
- Subcuject ApS
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Wearable Injectors Market, by Therapy
- 1.4.2 North America Wearable Injectors Market, by End User
- 1.4.3 North America Wearable Injectors Market, by Type
- 1.4.4 North America Wearable Injectors Market, by Technology
- 1.4.5 North America Wearable Injectors Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
- 3.2.5 Business Expansions
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018,Apr - 2022, Apr) Leading Players
Chapter 4. North America Wearable Injectors Market by Therapy
- 4.1 North America Diabetes Market by Country
- 4.2 North America Cardiovascular disease Market by Country
- 4.3 North America Immuno-oncology Market by Country
- 4.4 North America Others Market by Country
Chapter 5. North America Wearable Injectors Market by End User
- 5.1 North America Hospitals & Clinics Market by Country
- 5.2 North America Home healthcare setting Market by Country
Chapter 6. North America Wearable Injectors Market by Type
- 6.1 North America On-body Injector Market by Country
- 6.2 North America Off-body Injector Market by Country
Chapter 7. North America Wearable Injectors Market by Technology
- 7.1 North America Spring Based Market by Country
- 7.2 North America Motor Based Market by Country
- 7.3 North America Rotary pump Market by Country
- 7.4 North America Expanding battery Market by Country
- 7.5 North America Others Market by Country
Chapter 8. North America Wearable Injectors Market by Country
- 8.1 US Wearable Injectors Market
- 8.1.1 US Wearable Injectors Market by Therapy
- 8.1.2 US Wearable Injectors Market by End User
- 8.1.3 US Wearable Injectors Market by Type
- 8.1.4 US Wearable Injectors Market by Technology
- 8.2 Canada Wearable Injectors Market
- 8.2.1 Canada Wearable Injectors Market by Therapy
- 8.2.2 Canada Wearable Injectors Market by End User
- 8.2.3 Canada Wearable Injectors Market by Type
- 8.2.4 Canada Wearable Injectors Market by Technology
- 8.3 Mexico Wearable Injectors Market
- 8.3.1 Mexico Wearable Injectors Market by Therapy
- 8.3.2 Mexico Wearable Injectors Market by End User
- 8.3.3 Mexico Wearable Injectors Market by Type
- 8.3.4 Mexico Wearable Injectors Market by Technology
- 8.4 Rest of North America Wearable Injectors Market
- 8.4.1 Rest of North America Wearable Injectors Market by Therapy
- 8.4.2 Rest of North America Wearable Injectors Market by End User
- 8.4.3 Rest of North America Wearable Injectors Market by Type
- 8.4.4 Rest of North America Wearable Injectors Market by Technology
Chapter 9. Company Profiles
- 9.1 Insulet Corporation
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Approvals anf Trials:
- 9.2 United Therapeutics Corporation
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Product Launches and Product Expansions:
- 9.2.5.2 Acquisition and Mergers:
- 9.3 ATS Automation Tooling Systems, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional Analysis
- 9.4 Ypsomed AG
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Recent Strategies and Developments:
- 9.4.4.1 Partnerships, Collaborations, and Agreements:
- 9.4.4.2 Business Expansions:
- 9.5 Amgen, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.5 Recent Strategies and Developments:
- 9.5.5.1 Acquisitions and Mergers:
- 9.6 West Pharmaceutical Services, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent Strategies and Developments:
- 9.6.5.1 Partnerships, Collaborations and Agreements:
- 9.6.5.2 Product Launches and Product Expansions:
- 9.7 Zealand Pharma A/S (Valeritas, Inc.)
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Research & Development Expenses
- 9.7.4 Recent strategies and developments:
- 9.7.4.1 Partnerships, Collaborations and Agreements:
- 9.8 Medtronic PLC
- 9.8.1 Company overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Product Launches and Product Expansions:
- 9.8.5.2 Acquisition and Mergers:
- 9.9 CeQur SA
- 9.9.1 Company Overview
- 9.9.2 Recent strategies and developments:
- 9.9.2.1 Acquisition and Mergers:
- 9.10. Subcuject ApS
- 9.10.1 Company Overview
- 9.10.2 Recent strategies and developments:
- 9.10.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
- TABLE 1 North America Wearable Injectors Market, 2018 - 2021, USD Million
- TABLE 2 North America Wearable Injectors Market, 2022 - 2028, USD Million
- TABLE 3 Partnerships, Collaborations and Agreements- Wearable Injectors Market
- TABLE 4 Product Launches And Product Expansions- Wearable Injectors Market
- TABLE 5 Acquisition and Mergers- Wearable Injectors Market
- TABLE 6 Approvals and Trials - Wearable Injectors Market
- TABLE 7 Business Expansions- Wearable Injectors Market
- TABLE 8 North America Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
- TABLE 9 North America Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
- TABLE 10 North America Diabetes Market by Country, 2018 - 2021, USD Million
- TABLE 11 North America Diabetes Market by Country, 2022 - 2028, USD Million
- TABLE 12 North America Cardiovascular disease Market by Country, 2018 - 2021, USD Million
- TABLE 13 North America Cardiovascular disease Market by Country, 2022 - 2028, USD Million
- TABLE 14 North America Immuno-oncology Market by Country, 2018 - 2021, USD Million
- TABLE 15 North America Immuno-oncology Market by Country, 2022 - 2028, USD Million
- TABLE 16 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 17 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 18 North America Wearable Injectors Market by End User, 2018 - 2021, USD Million
- TABLE 19 North America Wearable Injectors Market by End User, 2022 - 2028, USD Million
- TABLE 20 North America Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
- TABLE 21 North America Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
- TABLE 22 North America Home healthcare setting Market by Country, 2018 - 2021, USD Million
- TABLE 23 North America Home healthcare setting Market by Country, 2022 - 2028, USD Million
- TABLE 24 North America Wearable Injectors Market by Type, 2018 - 2021, USD Million
- TABLE 25 North America Wearable Injectors Market by Type, 2022 - 2028, USD Million
- TABLE 26 North America On-body Injector Market by Country, 2018 - 2021, USD Million
- TABLE 27 North America On-body Injector Market by Country, 2022 - 2028, USD Million
- TABLE 28 North America Off-body Injector Market by Country, 2018 - 2021, USD Million
- TABLE 29 North America Off-body Injector Market by Country, 2022 - 2028, USD Million
- TABLE 30 North America Wearable Injectors Market by Technology, 2018 - 2021, USD Million
- TABLE 31 North America Wearable Injectors Market by Technology, 2022 - 2028, USD Million
- TABLE 32 North America Spring Based Market by Country, 2018 - 2021, USD Million
- TABLE 33 North America Spring Based Market by Country, 2022 - 2028, USD Million
- TABLE 34 North America Motor Based Market by Country, 2018 - 2021, USD Million
- TABLE 35 North America Motor Based Market by Country, 2022 - 2028, USD Million
- TABLE 36 North America Rotary pump Market by Country, 2018 - 2021, USD Million
- TABLE 37 North America Rotary pump Market by Country, 2022 - 2028, USD Million
- TABLE 38 North America Expanding battery Market by Country, 2018 - 2021, USD Million
- TABLE 39 North America Expanding battery Market by Country, 2022 - 2028, USD Million
- TABLE 40 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 41 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 42 North America Wearable Injectors Market by Country, 2018 - 2021, USD Million
- TABLE 43 North America Wearable Injectors Market by Country, 2022 - 2028, USD Million
- TABLE 44 US Wearable Injectors Market, 2018 - 2021, USD Million
- TABLE 45 US Wearable Injectors Market, 2022 - 2028, USD Million
- TABLE 46 US Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
- TABLE 47 US Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
- TABLE 48 US Wearable Injectors Market by End User, 2018 - 2021, USD Million
- TABLE 49 US Wearable Injectors Market by End User, 2022 - 2028, USD Million
- TABLE 50 US Wearable Injectors Market by Type, 2018 - 2021, USD Million
- TABLE 51 US Wearable Injectors Market by Type, 2022 - 2028, USD Million
- TABLE 52 US Wearable Injectors Market by Technology, 2018 - 2021, USD Million
- TABLE 53 US Wearable Injectors Market by Technology, 2022 - 2028, USD Million
- TABLE 54 Canada Wearable Injectors Market, 2018 - 2021, USD Million
- TABLE 55 Canada Wearable Injectors Market, 2022 - 2028, USD Million
- TABLE 56 Canada Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
- TABLE 57 Canada Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
- TABLE 58 Canada Wearable Injectors Market by End User, 2018 - 2021, USD Million
- TABLE 59 Canada Wearable Injectors Market by End User, 2022 - 2028, USD Million
- TABLE 60 Canada Wearable Injectors Market by Type, 2018 - 2021, USD Million
- TABLE 61 Canada Wearable Injectors Market by Type, 2022 - 2028, USD Million
- TABLE 62 Canada Wearable Injectors Market by Technology, 2018 - 2021, USD Million
- TABLE 63 Canada Wearable Injectors Market by Technology, 2022 - 2028, USD Million
- TABLE 64 Mexico Wearable Injectors Market, 2018 - 2021, USD Million
- TABLE 65 Mexico Wearable Injectors Market, 2022 - 2028, USD Million
- TABLE 66 Mexico Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
- TABLE 67 Mexico Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
- TABLE 68 Mexico Wearable Injectors Market by End User, 2018 - 2021, USD Million
- TABLE 69 Mexico Wearable Injectors Market by End User, 2022 - 2028, USD Million
- TABLE 70 Mexico Wearable Injectors Market by Type, 2018 - 2021, USD Million
- TABLE 71 Mexico Wearable Injectors Market by Type, 2022 - 2028, USD Million
- TABLE 72 Mexico Wearable Injectors Market by Technology, 2018 - 2021, USD Million
- TABLE 73 Mexico Wearable Injectors Market by Technology, 2022 - 2028, USD Million
- TABLE 74 Rest of North America Wearable Injectors Market, 2018 - 2021, USD Million
- TABLE 75 Rest of North America Wearable Injectors Market, 2022 - 2028, USD Million
- TABLE 76 Rest of North America Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
- TABLE 77 Rest of North America Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
- TABLE 78 Rest of North America Wearable Injectors Market by End User, 2018 - 2021, USD Million
- TABLE 79 Rest of North America Wearable Injectors Market by End User, 2022 - 2028, USD Million
- TABLE 80 Rest of North America Wearable Injectors Market by Type, 2018 - 2021, USD Million
- TABLE 81 Rest of North America Wearable Injectors Market by Type, 2022 - 2028, USD Million
- TABLE 82 Rest of North America Wearable Injectors Market by Technology, 2018 - 2021, USD Million
- TABLE 83 Rest of North America Wearable Injectors Market by Technology, 2022 - 2028, USD Million
- TABLE 84 Key Information - Insulet corporation
- TABLE 85 Key Information - United Therapeutics Corporation
- TABLE 86 Key Information - ATS Automation Tooling Systems, Inc.
- TABLE 87 Key Information - Ypsomed AG
- TABLE 88 Key Information - Amgen, Inc.
- TABLE 89 Key information - West Pharmaceutical Services, Inc.
- TABLE 90 Key Information - Zealand Pharma A/S
- TABLE 91 Key Information - Medtronic PLC
- TABLE 92 Key Information - CeQur SA
- TABLE 93 Key Information - Subcuject ApS
List of Figures
- FIG 1 Methodology for the research
- FIG 2 KBV Cardinal Matrix
- FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
- FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018,Apr - 2022, Apr) Leading Players
- FIG 5 Recent strategies and developments: United Therapeutics Corporation
- FIG 6 Recent strategies and developments: Ypsomed AG
- FIG 7 Recent Strategies and Developments: West Pharmaceutical Services, Inc.
- FIG 8 Recent strategies and developments: Medtronic PLC
